The Life Sciences Collection spans markets that are central to the life and wellbeing of the more than 7.5 billion people on our planet. From emerging diagnostics, to brand new therapies and treatment technologies, our expert analysts know where your focus – and investment – should be when it comes to biotechnology, pharmaceuticals and healthcare. As your senior editor, I look forward to introducing you to new opportunities.
These reports emphasize markets where technologies intersect with the building blocks of human life, including DNA, RNA, cancer, genomics, genetics, molecular diagnostics and more.
Globally, healthcare constitutes a multi trillion-dollar industry. Reports in this category span the range of treatments, administration practices and technologies available around the world.
751 Reports in Life Sciences
Just in 2017, medical cannabis totaled $7.3 billion, up from $4.8 billion in 2016. This segment will likely achieve a 22.2% CAGR to reach nearly $19.8 billion at the producer level in 2022 and will account to more than 80% of the global market. Politics aside, one must remember that marijuana is still a drug and needs to be treated as such with its potential side effects. Even if cannabinoids-based drugs will not fully substitute opioid use, combination of medical marijuana use with reduced dose of opioid will help to curb the crisis.
The global market for sensors should grow from $173.4 billion in 2019 to reach $323.3 billion by 2024 at a compound annual growth rate (CAGR) of 13.3% for the period of 2019-2024.
The global market for microbiome sequencing should grow from $885 million in 2018 to $2.0 billion by 2023 at a compound annual growth rate (CAGR) of 18.2% for the period of 2018-2023.
The global market for liquid biopsy should grow from $2.3 billion in 2018 to reach $6.1 billion by 2023 at a compound annual growth rate (CAGR) of 21.1% for the period of 2018-2023.
The report provides a detailed description of autoimmune responses and possible ways that drug development can augment immune responses so as to improve antitumor activity and reduce off target effect.This report will assess the latest developments in the IL-2 research and development and explore the novel strategies companies are adopting to augment immune response and avoid off target effects in a wide range of conditions including, metastatic melanoma (MM), renal cell carcinoma (RCC), urothelial cancers (US) relapse remitting multiple sclerosis (RRMS), Type 1 diabetes (T1D), as a prophylaxis post-transplant and allergic conditions.What's coming: There are more than 200 studies underway evaluating IL-2 based therapies either as a monotherapy or in combination. The key products and companies that we believe are worth watching in this space are summarized.
The global market for tissue engineering and regeneration should grow from $24.7 billion in 2018 to $109.9 billion by 2023 with a compound annual growth rate (CAGR) of 34.8% from 2018 to 2023.
The global longevity and anti-senescence therapies market should grow from $329.8 million in 2018 to $644.4 million by 2023 with a compound annual growth rate (CAGR) of 14.3% during 2018-2023.
The global radiopharmaceutical and therapeutics market should reach $22.0 billion by 2023 from $14.1 billion in 2018 at a compound annual growth rate (CAGR) of 9.2% for the period of 2018 to 2023.
The global sequencing market should grow from $10.7 billion in 2018 to $24.4 billion by 2023, with a compound annual growth rate (CAGR) of 18.0% for the period of 2018-2023.
The “Market at a Glance Pharmaceuticals” provides an access to all the market share analysis segments of the best-selling and key pharmaceutical reports of BCC Research. This report is a destination for the competitive landscape in the markets that hold a significant stand in the pharmaceuticals sector. Company profiles for all the notable manufacturers in the global pharmaceutical industry are provided as a part of this report.
The global market for exosome diagnostics and therapeutics should grow from $34.7 million in 2018 to $186.2 million by 2023, with a compound annual growth rate (CAGR) of 39.9% for the period of 2018-2023.
The global market for tumor-specific antigen should grow from $1.8 billion in 2018 to $2.4 billion by 2023 at a compound annual growth rate (CAGR) of 6.2% for the period of 2018-2023.
The global market for cell harvesting should grow from $885 million in 2018 to reach $1.5 billion by 2023 at a compound annual growth rate (CAGR) of 11.3% for the period of 2018-2023.
This special report provides a general overview of the orthopedic trauma fixation devices global markets and discusses the prospective growth opportunities. The coverage provides a focused view and articulates the challenges that need to be addressed for orthopedic trauma fixation devices to succeed in the global market.
Over the last year, a new $1.1 billion category of tech emerged with the purpose of helping women understand their health and well-being better than ever before: Femtech. As women have come to view fertility as a measure of their overall health—an interest no longer reserved exclusively for the prenatal set—more companies are disrupting the process of fertility awareness and contraception, as mbg investigated earlier this year, making cycle tracking a whole lot easier. Fertility apps like Daysy and Kindara come with a Bluetooth thermometer that syncs with your phone, making early-morning temperature readings super simple to record and decipher. Other companies like ava aim to make the whole experience less invasive (if thermometers aren’t your thing) by tracking vital signs via wrist wearables and delivering predictions and insights about fertility to their phone app. Some startups like Glowfocus solely on helping women get pregnant, but even Glow has a sister app, Eve, to track periods and sexual health.
For years, coastal consumers have enjoyed access to healthy foods, easily stumbling upon kombucha or probiotic-filled chocolates in trendy, niche boutiques and health food stores. This past year, we've seen larger corporations embrace wellness, starting a strong ripple effect and bringing better food at better prices to grocery stores across the country. These moves indicate a strong interest in millennials, a demographic with an estimated $1 trillion of buying power who are more dedicated to eating well and supporting ethical, sustainable business practices with their dollars than any other generation.
The global markets and technologies for optical coherence tomography (OCT) should reach $1.5 billion by 2023 from $993.9 million in 2018 at a compound annual growth rate (CAGR) of 8.8% for the period of 2018 to 2023.
The global liquid biopsy market should grow from $2.3 billion in 2018 to $6.1 billion by 2023, at a compound annual growth rate (CAGR) of 21.1% for the period of 2018-2023.
This report on global body countering devices market seeks to provide brief description of the devices that finds application in hospitals, clinics, and spa centers so that emerging market opportunities can be identified and utilized by the reader. The report achieves this objective by examining the main product applications and markets, helping companies for prioritizing the product opportunities and strategic opportunities.
The global market for chronic kidney disease should grow from $79.0 billion in 2018 to reach $95.0 billion by 2023 at a compound annual growth rate (CAGR) of 3.8% for the period of 2018-2023.
The global market for cell viability assays should grow from $2.7 billion in 2018 to reach $4.1 billion by 2023 at a compound annual growth rate (CAGR) of 8.3% for the period of 2018-2023.
Posttranslational modifications hit prime time in the pharma industry. There probably isn’t a medium sized biopharmaceutical that does not have an active program ongoing, and certainly all of the big pharma companies are running multiple programs, and collaborations, for what we might have previously termed “undruggable targets”. Many of these are for highly unmet needs in neurodegeneration. The properties of the structure that forms between a target, a degrader and an E3 ligase, are under intense investigation. Minor changes affect how the drugs work - this can explain how promiscuous target-binding payloads can achieve super selectivity when transformed into a degrader. These minor alterations can also render the molecule complex not only ineffective, but sometimes toxic. However, clinical results are beginning to write a compellingly effective story – the long and winding history of research into the ubiquitin proteasome may well have more blockbusters in store for us. And cures in a once overlooked corner of the cell machinery architecture.
The global market for validation, calibration and standardization in the global life sciences should grow from $1.5 billion in 2018 to reach $2.1 billion by 2023 at a compound annual growth rate (CAGR) of 6.7% for the period of 2018-2023.
The global market for biodegradable stents should grow from $106.7 million in 2018 to $378.0 million by 2023 with a compound annual growth rate (CAGR) of 28.8% for the period of 2018-2023.
The global bioprinting market should reach $1.4 billion by 2024 from $306.2 million in 2019 at a compound annual growth rate (CAGR) of 35.4% for the period 2019 to 2024.
26 Upcoming Reports in Life Sciences
GxP/GMP Regulation Testing, Services Market in Food, Pharmaceuticals, Medical Devices, and Cosmetics
The goal of this study is to provide a multidimensional view of the global GxP/GMP regulation testing service market.
This report provides an overview of the current state of stem cell and regenerative medicines industry, recent technologies and platforms, market participants and its future direction
This report determines the present status of the worldwide catheter market and evaluates its potential over the five-year period.
You should know this tumor infiltrating lymphocytes a new frontier in cancer immunotherapy market research report by Dr. Cheryl Lee Barton.
This report provides an overview of the current state of human identification industry, recent technologies and platforms, market participants and its potential customers.
This study analyzes the organ on a chip market and provides assessment of the global growth potential through 2023, including current and future commercial potential for each of the key market segments.
5G wireless in healthcare—products such as wireless medical devices, electronic health records (EHR) and remote surgical equipment. In addition, pharmaceutical companies are harvesting Big Data from wireless applications to make drug development and clinical testing more efficient.
The report offers an exhaustive description and evaluation of the single use technologies and bioreactors for pharmaceuticals. It provides in-depth qualitative and quantitative insights of the report, which aligns with the goals and objectives of intended audience.
This report provides a complete review and analysis of the current POC markets, and forecasts the market through 2023. In addition, it provides an examination and description of select products, current and emerging technologies, and company profiles.
PCR for POC Diagnostics
BCC Research analyst Todd Graham delves into the markets being served by the new technology for polymerase chain reaction for point-of-care diagnostics, sharing the uses, outlook, and more on these clinical diagnostic kits. Recorded live on May 16, 2018.
How to Dissect a Market Opportunity
BCC Research Senior Editor Gordon Nameni shares how to interpret market research to uncover market opportunities at a live event on September 12, 2017, in Boston, MA.